K. Taniguchi
- Co-authors
- Rolf KiesslingK NomotoAlvar GrönbergHans‐Gustaf LjunggrenGeorge KleinGerald E. PiontekK KärrePetter Höglund
- Topics
- Immune Cell Function and Interaction (8 papers)Cancer Immunotherapy and Biomarkers (5 papers)Lung Cancer Treatments and Mutations (5 papers)
- Cited by
- ImmunologyOncologyMicrobiology
- Journals
- Proceedings of the National Academy of SciencesThe Journal of ImmunologyAntimicrobial Agents and Chemotherapy
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
K. Taniguchi
33 papers receiving 593 citations
Peers
Comparison fields: 5 of 84
- Immunology 374
- Oncology 150
- Molecular Biology 123
- Epidemiology 63
- Pulmonary and Respiratory Medicine 59
Countries citing papers authored by K. Taniguchi
This map shows the geographic impact of K. Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Taniguchi more than expected).
Fields of papers citing papers by K. Taniguchi
This network shows the impact of papers produced by K. Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Taniguchi. The network helps show where K. Taniguchi may publish in the future.
Co-authorship network of co-authors of K. Taniguchi
This figure shows the co-authorship network connecting the top 25 collaborators of K. Taniguchi. A scholar is included among the top collaborators of K. Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Taniguchi. K. Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 33 | |
| 6 | 1 | |
| 7 | 16 | |
| 8 | 51 | |
| 9 | 12 | |
| 10 | Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins. | 22 |
| 11 | 11 | |
| 12 | AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion. | 2 |
| 13 | 7 | |
| 14 | 139 | |
| 15 | 6 | |
| 16 | 1 | |
| 17 | The mechanism of reduction of cell-mediated cytotoxicity in neonatally thymectomized mice. | 12 |
| 18 | Direct cytotoxicity against chicken erythrocytes in mice. II. Nature of immunoglobulin on cytotoxic T lymphocytes. | 2 |
| 19 | Direct cytotoxicity against chicken erythrocytes in mice. III. Degrees of radiosensitivity and cross-reactivity of cytotoxicity, delayed hypersensitivity and antibody production. | 3 |
| 20 | Relationships among differentiated T-cell subpopulations. III. Radioresistance of delayed hypersensitivity to heterologous erythrocytes. | 10 |
About K. Taniguchi
K. Taniguchi is a scholar working on Immunology, Oncology and Toxicology, having authored 35 papers that have together received 620 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Immunology (374 citations), Oncology (150 citations) and Microbiology (29 citations). K. Taniguchi has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Rolf Kiessling, K Nomoto, Alvar Grönberg, Hans‐Gustaf Ljunggren, George Klein, Gerald E. Piontek, K Kärre, Petter Höglund, Klas Kärre and Max Petersson. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.